ClinConnect ClinConnect Logo
Search / Trial NCT00171652

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Launched by NOVARTIS · Sep 13, 2005

Trial Information

Current as of May 24, 2025

Completed

Keywords

Hand Osteoarthritis, Topical Nsaid, Diclofenac Sodium

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Key Inclusion criteria:
  • • Osteoarthritis of the hand
  • Key Exclusion Criteria:
  • Other rheumatic disease, such as rheumatoid arthritis
  • Active gastrointestinal ulcer during the last year
  • Known allergy to analgesic drugs

About Novartis

Novartis is a global healthcare company based in Switzerland, dedicated to reimagining medicine to improve and extend people's lives. With a strong focus on innovative pharmaceuticals, Novartis engages in the research, development, and commercialization of a wide range of therapies across various therapeutic areas, including oncology, cardiology, immunology, and neuroscience. The company is committed to advancing clinical research through rigorous trials that prioritize patient safety and efficacy, aiming to deliver groundbreaking treatments and solutions that address unmet medical needs worldwide. Novartis's commitment to innovation and collaboration positions it at the forefront of the biopharmaceutical industry, driving advancements that enhance patient care and health outcomes.

Locations

Karlsruhe, , Germany

Berlin, , Germany

Bochum, , Germany

Dortmund, , Germany

Bad Hersfeld, , Germany

Nantes, , France

Paris, , France

Bad Nauheim, , Germany

Hamburg, Hh, Germany

Paris, , France

Cergy, , France

Clamart, , France

Cournonterral, , France

Fellering, , France

Goussonville, , France

Linas, , France

Longpont Sur Orge, , France

Meaux, , France

Nantes, , France

Orly, , France

Savigny Sur Orge, , France

Thouars, , France

Villeneuve Le Roi, , France

Berlin, , Germany

Dinslaken, , Germany

Dreieich, , Germany

Dresden, , Germany

Frankfurt A/M, , Germany

Hagen, , Germany

Hamburg, , Germany

Karlsruhe, , Germany

Kassel, , Germany

Leipzig, , Germany

Ludwigshafen, , Germany

München, , Germany

Neustadt/Aisch, , Germany

Nürnberg, , Germany

Stuttgart, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials